Longlong Bao
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Clinical Impact of BTK Inhibitor Exposure in LymphGen-Defined MCD Diffuse Large B-Cell Lymphoma.
Journal: Hematological oncology
Published: June 04, 2026
Zanubrutinib combined with R-CHOP in previously untreated diffuse large B-cell lymphoma with specific gene alteration: a phase II study.
Journal: Blood cancer journal
Published: January 01, 2026
Correlation of TP53 Genetic Alterations with p53 Immunohistochemical Expression and Their Prognostic Significance in DLBCL.
Journal: Current oncology (Toronto, Ont.)
Published: June 23, 2025
Clinicopathological Features of CCDC6-RET and NCOA4-RET Fusions in Thyroid Cancer: A Single-Center Retrospective Cohort Study in a Chinese Population.
Journal: Thyroid : official journal of the American Thyroid Association
Published: August 30, 2024
Characteristics and Clinical Value of MYC , BCL2, and BCL6 Rearrangement Detected by Next-generation Sequencing in DLBCL.
Journal: The American journal of surgical pathology
Published: June 27, 2024
Invasive Breast Cancer with HER2 ≥4.0 and <6.0: Risk Classification and Molecular Typing by a 21-Gene Expression Assay and MammaPrint Plus BluePrint Testing.
Journal: Breast cancer (Dove Medical Press)
Published: May 24, 2023
Clinical Genetic Features and Neoadjuvant Chemotherapy Response in HER2-Low Breast Cancers: A Retrospective, Multicenter Cohort Study.
Journal: Annals of surgical oncology
Published: November 11, 2022
Diagnostic performance of next-generation sequencing and genetic profiling in thyroid nodules from a single center in China.
Journal: European thyroid journal
Published: April 19, 2022
Clinicopathological and molecular characteristics of fumarate hydratase-deficient uterine smooth muscle tumors: a single-center study of 52 cases.
Journal: Human pathology
Published: April 04, 2022
Mutation Landscape of Homologous Recombination Repair Genes in Epithelial Ovarian Cancer in China and Its Relationship With Clinicopathlological Characteristics.
Journal: Frontiers in oncology
Published: June 25, 2021
Germline and tumor BRCA1/2 mutations in Chinese high grade serous ovarian cancer patients.
Journal: Annals of translational medicine
Published: April 14, 2021
Germline and tumor BRCA1/2 pathogenic variants in Chinese triple-negative breast carcinomas.
Journal: Journal of cancer research and clinical oncology
Published: February 20, 2021
Last Updated: 09/26/2026